Drug intelligence / Profile preview

euphorbia antiquorum latex

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical, Oral
01

Overview

Euphorbia antiquorum latex is a botanical extract derived from the succulent plant *Euphorbia antiquorum*, commonly known as the ancient euphorbia or square spurge. In oncological research, the latex has demonstrated significant anti-tumor activity, particularly against human cervical adenocarcinoma (HeLa) cells. Its mechanism of action involves the induction of apoptosis through both the intrinsic mitochondrial pathway and the extrinsic death receptor pathway. Treatment with the latex leads to the activation of caspases-3, -8, and -9, the upregulation of pro-apoptotic proteins like Bax, Fas, and FasL, and the downregulation of the anti-apoptotic protein Bcl-2. Additionally, it triggers the generation of reactive oxygen species (ROS) and modulates mitogen-activated protein kinase (MAPK) signaling by activating JNK and p38 while inhibiting the phosphorylation of ERK1/2.

Other names
EA latexlatex of Euphorbia antiquorum
02

Targets

ATM (Ataxia telangiectasia mutated protein)BAX (Apoptosis regulator BAX)CASP3 (Caspase-3)CASP9 (Caspase-9)RK (Ribokinase)CASP8 (Caspase-8)MAPK3 (Mitogen-activated protein kinase 1)JNK (Mitogen-activated protein kinase kinase kinase family)

Beyond the preview

Go deeper on euphorbia antiquorum latex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on euphorbia antiquorum latex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call